OBSOLETE: Heinz body anemia

Heinz body anemia is an obsolete clinical term that was historically used to describe hemolytic anemias characterized by the presence of Heinz bodies within red blood cells. Heinz bodies are inclusions composed of denatured or precipitated hemoglobin that attach to the red blood cell membrane, causing cellular rigidity and premature destruction of red blood cells (hemolysis). This term is no longer used as a distinct diagnostic entity in modern clinical genetics and hematology, as the underlying causes have been better characterized and reclassified into specific diagnoses. Heinz body formation can occur in several well-defined genetic conditions, most notably glucose-6-phosphate dehydrogenase (G6PD) deficiency, unstable hemoglobin variants (also known as congenital Heinz body hemolytic anemia), and other red cell enzyme deficiencies. It can also be triggered by exposure to certain oxidant drugs or chemicals. Symptoms typically include anemia, jaundice, dark urine, fatigue, and splenomegaly due to the accelerated destruction of red blood cells in the spleen and reticuloendothelial system. Because this Orphanet entry (ORPHA:178330) is designated as obsolete, patients and clinicians should refer to the specific underlying diagnosis for accurate genetic counseling, management, and treatment information. Treatment approaches vary depending on the specific etiology but may include avoidance of oxidant triggers, folic acid supplementation, blood transfusions for severe anemia, and in some cases splenectomy.

Common questions about OBSOLETE: Heinz body anemia